Keymed Biosciences, Inc. had a revenue of 373.44M in the quarter ending Dec 31, 2024, with 582.93%. This bring the company's revenue in the last twelve months to 428.12M, Decreased 424.32%. In the fiscal year ending Dec 31, 2024, Keymed Biosciences, Inc. had annual revenue of 428.12M with 20.91% growth.